Hospira Inc. recalls DOBUTamine Injection, USP 250 mg/20 mL, 20 mL Vial, For IV U
See all recalls from Hospira Inc. →Recalled Product
DOBUTamine Injection, USP 250 mg/20 mL, 20 mL Vial, For IV Use Only, Must be Diluted Prior to Use, (12.5 mg per mL), Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2025-20
Hazard / Issue
Discoloration: Firm received complaints of product discoloration and particulates.
Issued by
FDA
Distribution: Nationwide (United States)
Lot/Code Info: Lot #: 52175DD, Exp 01 Oct 2016
✅ What Should You Do?
- 1Stop taking this medication and contact your doctor or pharmacist immediately.
- 2Do NOT flush medications down the drain — use an FDA-approved drug take-back program.
- 3Check the lot number on your bottle or packaging against the recalled lots listed above.
- 4Report adverse events to FDA MedWatch or call 1-800-FDA-1088.
Looking for a safe alternative?
Search Amazon for DOBUTamine Injection, USP 250 →If you were harmed by this recalled product, Top Class Actions lists active class action lawsuits and settlements that may apply to you.
Get the next US recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CAN-SPAM compliant · No spam · Unsubscribe anytime